Unique ID issued by UMIN | UMIN000053685 |
---|---|
Receipt number | R000060435 |
Scientific Title | Effects of lysolecithin intake on brain function and blood choline concentration: A randomized, double-blinded, placebo-controlled trial in healthy middle-aged and elderly volunteers |
Date of disclosure of the study information | 2024/02/22 |
Last modified on | 2024/02/22 16:14:03 |
Effects of lysolecithin intake on brain function in healthy middle-aged and elderly volunteers
Effects of lysolecithin intake on brain function
Effects of lysolecithin intake on brain function and blood choline concentration: A randomized, double-blinded, placebo-controlled trial in healthy middle-aged and elderly volunteers
Effects of lysolecithin intake on brain function: A randomized, double-blinded, placebo-controlled trial in healthy volunteers
Japan |
Healthy subjects
Adult |
Others
NO
This study aims to investigate the effects of lysolecithin intake on brain function.
Efficacy
Exploratory
Memory scores assessed using the Wechsler Memory Scale-Revised
・Performance on a calculation task
・Mental functions assessed using a visual analog scale
・Blood concentrations of choline and lysophosphatidylcholine
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Intake of placebo capsules for 8 weeks
Intake of lysolecithin capsules for 8 weeks
40 | years-old | <= |
74 | years-old | >= |
Male and Female
1. Provided written informed consent to participate in the study
2. Healthy adults aged 40-74 years at the time of the consent
1. A self-reported history of brain, nerve, or mental disorders, which the Clinical Investigator believes confounds the interpretation of the study results
2. Having a sleep problem
3. Having a digestive problem or a history of digestive disorders, which the Clinical Investigator believes affects the absorption of the test supplement
4. Taking medicines or supplements that could affect brain, nerve, or mental function or sleep within 1 week of study commencement
5. Having a blood pressure or pulse rate that extremely deviates from the normal range
6. Having soy allergy
7. Not meeting certain criteria related to visual acuity
8. Other conditions judged by the Clinical Investigator to be inappropriate for the study
46
1st name | Koichiro |
Middle name | |
Last name | Hamada |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Aza Higashiyama, Omagari, Yoshinogari-cho, Kanzaki-gun, Saga, Japan
+81-952-52-1522
hamadako@otsuka.jp
1st name | Ryohei |
Middle name | |
Last name | Tanaka-Kanegae |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Aza Higashiyama, Omagari, Yoshinogari-cho, Kanzaki-gun, Saga, Japan
+81-952-52-1522
Tanaka.Ryohei@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Profit organization
Hakata Clinic Institutional Review Board
6-18 Tenyamachi, Hakata-ku, Fukuoka, Fukuoka 812-0025, Japan
+81-92-283-7701
miyako-koga@lta-med.com
NO
医療法人相生会ピーエスクリニック
SOUSEIKAI PS Clinic
2024 | Year | 02 | Month | 22 | Day |
Unpublished
46
Delay expected |
The analysis has not been completed.
Completed
2017 | Year | 02 | Month | 17 | Day |
2017 | Year | 03 | Month | 03 | Day |
2017 | Year | 03 | Month | 14 | Day |
2017 | Year | 08 | Month | 16 | Day |
2024 | Year | 02 | Month | 22 | Day |
2024 | Year | 02 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060435
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |